311 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
with any person or entity other than the corporation with respect to any direct or indirect compensation or reimbursement for service as a Director that has
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement
8-K
8ig8tbzihda zu6rjs
5 Jan 24
Other Events
5:50pm
8-K
t50pvkb7 ns4v4
1 Dec 23
Entry into a Material Definitive Agreement
8:25am
8-K
7wcyjs
18 Oct 23
Other Events
9:03am
8-K
EX-10.1
jxmds8 7zkc4iz
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
xjwmylhvce19xenc1y
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
S-8
zwd4gyzwceir490z
10 Aug 22
Registration of securities for employees
4:05pm
S-8
qh00rygwi6ccvbnhsj
13 Jun 22
Registration of securities for employees
8:44am
425
158kdye81bu7kmmf n7
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
frt0jye
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
hrje1oob
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
y4bt 1fs3
24 Mar 22
Entry into a Material Definitive Agreement
9:08am